AstraZeneca diabetes drug Farxiga meets goal in heart failure trial Medical Dialogues Bureau23 Aug 2019 9:15 AM ISTFarxiga, already one of AstraZeneca’s top 10 drugs by sales, met the main goal of the so-called DAPA-HF trial, which tested the medicine in addition...
Nabriva Therapeutics 2 pneumonia antibiotic versions priced at over Rs 14000 per day Medical Dialogues Bureau23 Aug 2019 9:00 AM ISTThe drug Xenleta, also called lefamulin, works by interfering with the bacteria's ability to replicate. It's the first drug by Nabriva Therapeutics to...
Zydus Cadila gets USFDA nod for Ranolazine Extended-Release tablets to treat chronic angina Medical Dialogues Bureau22 Aug 2019 10:00 AM ISTThe company has received approval for Ranolazine Extended-Release tablets from the United States Food and Drug Administration (USFDA) to market the...
Lupin to sell Japanese injectables business to Abu-Dhabi based Neopharma group Medical Dialogues Bureau22 Aug 2019 9:50 AM IST"Under the terms of the agreement, Lupin has agreed to sell all the issued and outstanding share capital in Kyowa Criticare Co Ltd to neo-ALA Co Ltd....
Pfizer infuses Rs 3597 crore to expand gene therapy plant in Sanford Medical Dialogues Bureau22 Aug 2019 9:30 AM ISTThe investment will add additional capacity and capabilities to a facility that makes some of Pfizer's most closely watched experimental...
AstraZeneca gets marketing authorization for Roxadustat in China to treat anaemia caused by CKD Medical Dialogues Bureau22 Aug 2019 9:20 AM ISTThis marketing authorization follows the approval of Roxadustat in China in December 2018 for anaemia in CKD patients who are on dialysis. AstraZeneca...
GSK: US pharma president Jack Bailey to step down in December Medical Dialogues Bureau22 Aug 2019 9:15 AM ISTCommenting on his time at GSK, Jack Bailey said, "After more than a decade at GSK and nearly three decades in the life sciences industry, I look...
Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh Medical Dialogues Bureau21 Aug 2019 10:00 AM ISTThe audit of Dr Reddy's formulations manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam by the United States Food and Drug...
Alembic Pharma clears USFDA inspection at Bioequivalence facility in Vadodara Medical Dialogues Bureau21 Aug 2019 9:45 AM ISTNew Delhi: Drug firm, Alembic Pharmaceutical's bioequivalence facilities located at Vadodara have been successfully inspected by the US Food &...
Dr Reddy's launches generic version of Sabril powder in US to treat epilepsy Medical Dialogues Bureau21 Aug 2019 9:30 AM ISTDr Reddy's anti-epileptic Vigabatrin is a generic version of Lundbeck's Sabril powder for oral solution.New Delhi: Drug firm Dr Reddy's Laboratories...
Teva Pharma unveils generic version of EpiPen for children at USD 300 for 2 packs Medical Dialogues Bureau21 Aug 2019 9:15 AM ISTTeva Pharma, the world’s largest generic drugmaker, is already selling the product for adults, after getting U.S. approval for its copy of EpiPen last...
Bayer sells Animal Health unit to US drug firm Elanco for USD 7.6 billion Medical Dialogues Bureau21 Aug 2019 9:00 AM ISTBayer said in a statement that the sale, aimed at sharpening the company's focus on life sciences, was expected to be concluded in mid-2020 pending...
